Fertility

Extend Fertility Reports High Success Rates in 8-Year Egg Freezing Study

Extend Fertility has released the results of an 8-year comprehensive study on egg freezing success rates, providing new insights into the effectiveness of fertility preservation. The findings, presented at the American Society of Reproductive Medicine Conference in Denver, demonstrate significant success rates and changing trends in egg freezing demographics. The study, which followed 3,100 unique patients through 4,600 egg freezing cycles between…

Celmatix Achieves Milestone in Development of Oral Fertility Drug

In what could mark a significant shift in fertility treatment, Celmatix has announced the nomination of its first lead compound in its oral Follicle Stimulating Hormone receptor (FSHR) agonist drug development program. The breakthrough, announced during the American Society for Reproductive Medicine (ASRM) annual meeting in Denver, could potentially transform fertility treatments by replacing traditional hormone injections with oral medications. The development…

Legacy and Posterity Health Partner to Expand Male Fertility Care Access

Legacy, a leading sperm testing and freezing company in the U.S., and Posterity Health, a virtual-first soltuion for male reproductive health, have announced a partnership to provide end-to-end male fertility and hormone health care. The collaboration creates a hybrid care model combining Legacy’s at-home testing capabilities with Posterity Health’s specialized treatment services. The program offers baseline semen analysis through Legacy to understand…

Astec Acquires Presagen’s AI Fertility Product Life Whisperer

Astec, a global manufacturer of medical equipment for assisted reproduction, has acquired Life Whisperer, the AI fertility product developed by Presagen. Life Whisperer is a non-invasive and rapid embryo and egg (oocyte) assessment tool designed to improve pregnancy outcomes for IVF patients. Life Whisperer consists of three AI algorithms. The first, Life Whisperer Viability, assesses images of embryos to determine the likelihood…

PatientFi and EngagedMD Partner to Improve Fertility Treatment Financing

PatientFi, a fertility financing company, and EngagedMD, a patient engagement platform, have announced a strategic partnership aimed at improving access to fertility treatment financing. The collaboration integrates financing education into EngagedMD’s platform, allowing clinics to provide patients with information on funding options early in the treatment process. The partnership addresses the financial barriers to fertility treatment by offering video modules within the…

Levy Health Secures $4.5M Seed Funding to Accelerate Fertility Diagnosis

Levy Health has raised $4.5 million in seed funding to further develop its clinical decision support platform for fertility diagnosis. The round was led by XYZ Ventures, with participation from Atlantic Labs and Possible Ventures. Founded in 2022 by Caroline Mitterdorfer, Silvia Hecher, and Dr. Theresa Vilsmaier, Levy Health aims to speed up the process of diagnosing fertility issues in women. The…

Consumer Health Startup Beli Expands from Supplements to At-Home Fertility Testing for Men and Women

Beli, a company known for its fertility and prenatal supplements, has launched at-home fertility testing kits for both men and women. This new offering aims to provide users with data-driven insights into their reproductive health, complementing Beli’s existing line of supplements. The company has partnered with IHDLab to develop these testing kits. For men, the test measures four key fertility hormones: Testosterone,…

Amazon Switches to Maven Clinic for Fertility Benefits

In a significant move that’s turning heads in the fertility benefits industry, e-commerce giant Amazon has reportedly chosen Maven Clinic to replace Progyny as its primary fertility benefits provider. This development, highlighted in a recent J.P. Morgan analyst report, marks a notable moment in the competitive landscape of digital health and family care services. Anu Duggal, an investor in Maven through Female…